Cargando…

Bisphosphonates: are they standard of care for the treatment of breast cancer?

Detalles Bibliográficos
Autor principal:	Pritchard, K I
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2007
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359974/ https://www.ncbi.nlm.nih.gov/pubmed/17565339 http://dx.doi.org/10.1038/sj.bjc.6603836

Ejemplares similares

The role of bisphosphonates in breast cancer: Development of bisphosphonates
por: Fleisch, Herbert
Publicado: (2002)

Bisphosphonates for osteoarthritis
por: Walsh, David A, et al.
Publicado: (2011)

Have we been guilty of ageism in the primary treatment of breast cancer?
por: Pritchard, K I
Publicado: (2007)

The role of bisphosphonates in breast cancer: Direct effects of bisphosphonates on breast cancer cells
por: Senaratne, Siddhika G, et al.
Publicado: (2002)

The role of bisphosphonates in breast cancer: Actions of bisphosphonates in animal models of breast cancer
por: Padalecki, Susan S, et al.
Publicado: (2002)

Bisphosphonates in the adjuvant treatment of early breast cancer
por: Gnant, M
Publicado: (2009)

The role of bisphosphonates in breast cancer: The present and future role of bisphosphonates in the management of patients with breast cancer
por: Brown, Janet E, et al.
Publicado: (2002)

Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition
por: Van Poznak, Catherine
Publicado: (2010)

Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk
por: Newcomb, P A, et al.
Publicado: (2010)

Adoption of adjuvant bisphosphonates for early breast cancer into standard clinical practice: Challenges and lessons learnt from comparison of the UK and Australian experience
por: Porter, I., et al.
Publicado: (2021)

Bisphosphonates induce apoptosis in human breast cancer cell lines
por: Senaratne, S G, et al.
Publicado: (2000)

Current Controversies in Classification, Management, and Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw
por: Ascani, Giuliano, et al.
Publicado: (2014)

Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting
por: Jacobs, Carmel, et al.
Publicado: (2015)

Age-related differences in persistence with bisphosphonates in women with metastatic breast cancer
por: Jacob, L., et al.
Publicado: (2016)

Bisphosphonates in the Treatment of Patients With Metastatic Breast, Lung, and Prostate Cancer: A Meta-Analysis
por: Liu, Jing, et al.
Publicado: (2015)

Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer
por: Palmieri, C, et al.
Publicado: (2013)

ERT, HRT, Raloxifine, Calcitonin, or Bisphosphonates for Osteoporosis
por: Curtiss, Frederic R.
Publicado: (2003)

Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer
por: Liauw, Winston, et al.
Publicado: (2005)

Anti-tumour activity of bisphosphonates in preclinical models of breast cancer
por: Holen, Ingunn, et al.
Publicado: (2010)

Bisphosphonates adherence for treatment of osteoporosis
por: Vieira, Helena Parente, et al.
Publicado: (2013)

Adjuvant colon cancer chemotherapy: Is there an Indian standard of care?
por: Joshi, Rohit
Publicado: (2013)

Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results
por: Diel, I J, et al.
Publicado: (2000)

Highly different risk estimates for atypical femoral fracture with use of bisphosphonates – debate must be allowed!
Publicado: (2012)

Prostate cancer and hypofractionation: really a new standard of care?
por: Carrie, Christian, et al.
Publicado: (2016)

Should all adjuvant breast cancer patients receive a bisphosphonate?
por: Cameron, David A
Publicado: (2003)

Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence
por: Santini, Daniele, et al.
Publicado: (2015)

Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells
por: Ebert, Regina, et al.
Publicado: (2014)

Association Use of Bisphosphonates with Risk of Breast Cancer: A Meta-Analysis
por: Peng, Rui, et al.
Publicado: (2020)

Oral bisphosphonates and colorectal cancer
por: Vogtmann, Emily, et al.
Publicado: (2017)

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel
por: Jagdev, S P, et al.
Publicado: (2001)

The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws
por: Lee, Emily Sunny, et al.
Publicado: (2023)

Bisphosphonates: An update
por: Ganapathy, Nalliappan, et al.
Publicado: (2012)

Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells
por: Journé, Fabrice, et al.
Publicado: (2008)

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer.
por: Coleman, R. E., et al.
Publicado: (1987)

Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: A systematic review
por: Varun, BR, et al.
Publicado: (2012)

Correction to: The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

Minimum (optimum) standard of orthopedic care for all: An achievable target
por: Jain, Anil K
Publicado: (2014)

Rapid transitions in the standard of care for chronic lymphocytic leukemia (CLL)
por: Seymour, Erlene K.
Publicado: (2019)

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
por: Vale, Claire L, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kjht075qre57u1r9cd47gmv1of